Výsledky vyhledávání - "F. Joseph Daugherty"

Akademický článek

The effects of phosphocreatine disodium salts plus blueberry extract supplementation on muscular strength, power, and endurance

Autor: John Paul V. Anders, Tyler J. Neltner, Robert W. Smith, Joshua L. Keller, Terry J. Housh, F. Joseph Daugherty, Michael S. Tempesta, Alekha K. Dash, Daniel J. Munt, Richard J. Schmidt, Glen O. Johnson

Publikováno v: Journal of the International Society of Sports Nutrition, Vol 18, Iss 1 (2021)

Background Numerous studies have demonstrated the efficacy of creatine supplementation for improvements in exercise performance. Few studies, however, have examined the effects of phosphocreatine supplementation on exercise performance. Furthermore,

Externí odkaz: https://doaj.org/article/bff4dd5cc4d6457695910c4160334a97

Zobrazit plný text záznamu

Abstract OT2-10-06: Phase III study to evaluate the efficacy and safety of GLSI-100 (GP2 + GM-CSF) in breast cancer patients with residual disease or high-risk PCR after both neo-adjuvant and postoperative adjuvant anti-HER2 therapy, Flamingo-01

Autor: Snehal Patel, Jaye Thompson, Mira Patel, F. Joseph Daugherty, C. Kent Osborne, Mothaffar Rimawi

Publikováno v: Cancer Research. 83:OT2-10

Background: GP2 is a biologic nine amino acid peptide of the HER2/neu protein delivered in combination with Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) that stimulates an immune response targeting HER2/neu expressing cancers, the combin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::70b78288804ccc8415b4469090100f41
https://doi.org/10.1158/1538-7445.sabcs22-ot2-10-06

Zobrazit plný text záznamu

Abstract CT064: Phase III study to evaluate the efficacy and safety of GLSI-100 (GP2 + GM-CSF) in breast cancer patients with residual disease or high-risk PCR after both neo-adjuvant and postoperative adjuvant anti-HER2 therapy, Flamingo-01

Autor: Snehal S. Patel, Jaye L. Thompson, Mira S. Patel, F. Joseph Daugherty, Mothaffar F. Rimawi

Publikováno v: Cancer Research. 83:CT064-CT064

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::507b66206d5df80f149357b9b3dc03b7
https://doi.org/10.1158/1538-7445.am2023-ct064

Zobrazit plný text záznamu

Abstract CT161: GP2 immune response a predictor of recurrence in a phase IIb study evaluating HER2/neu peptide GP2 (GLSI-100) vs. GM-CSF alone after adjuvant trastuzumab in HER2 positive women with breast cancer

Autor: Snehal S. Patel, David B. McWilliams, Mira S. Patel, Jaye Thompson, F. Joseph Daugherty

Publikováno v: Cancer Research. 82:CT161-CT161

The authors did not submit an updated abstract. The original abstract should be considered final. Citation Format: Snehal S. Patel, David B. McWilliams, Mira S. Patel, Jaye Thompson, F. Joseph Daugherty. GP2 immune response a predictor of recurrence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b2b9b15632f4536e5e06376c7183e35e
https://doi.org/10.1158/1538-7445.am2022-ct161

Zobrazit plný text záznamu

Evaluation of booster injections in maintaining peak immunity in a phase IIb study evaluating HER2/neu peptide GP2 (GLSI-100) versus GM-CSF alone after adjuvant trastuzumab in women with HER2-positive breast cancer

Autor: Snehal Patel, David McWilliams, Jaye Thompson, Mira Patel, F. Joseph Daugherty

Publikováno v: Journal of Clinical Oncology. 40:LBA550-LBA550

LBA550 Background: Injection site reactions (ISR) of booster injections in the randomized, active-controlled, single-blinded, multicenter Phase IIb trial of GLSI-100 (GP2+GM-CSF) administered in the adjuvant setting to node-positive and high-risk nod

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::332fe08e17382c93508648ec9509b4c0
https://doi.org/10.1200/jco.2022.40.17_suppl.lba550

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání